Thrombosis Guideline

Guidelines for the use of anticoagulants and Thrombolytic agents in children

  • Guidelines for unfractionated heparin therapy [UFH]
  • Protocol for low molecular weight heparin [LMWH] therapy with enoxaparin and tinzaparin
  • Guidelines for warfarin therapy
  • Guidelines for over-anticoagulation with warfarin
  • Guidelines for elective reversal of warfarin therapy
  • Guidelines for systemic thrombolytic therapy
  • Guidelines for management of pediatric patients with Deep Vein Thrombosis/Pulmonary Embolism (DVT/PE)
  • Guidelines for management of pediatric patients with inherited Thrombophilia
  • Management of Blocked Central Venous Access Devices
  • Anticoagulation guidelines for patients with Fontan repair
  • Anticoagulation guidelines for Blalock-Taussig shunts
  • Anticoagulation guidelines for valve replacement
  • Anticoagulation guidelines for patients with endovascular stents and vascular dilatation procedures
  • Approach to acute cerebral arterial infarct
  • Cerebral sinovenous thrombosis

The supportive care guidelines have been developed by appropriate Atlantic Provinces health professional specialists (physicians, pharmacists, nurses and other health professionals) using evidence-based or best practice references.  Format and content of the guidelines will change as they are reviewed and revised on a periodic basis.  Care has been taken to ensure accuracy of the information.  However, any physician or health professional using these guidelines will be responsible for verifying doses, and administering medications and care according to their own institutional formularies and policies and acceptable standards of care. 

Link to 2012 APPHON/ROHPPA Thrombosis Guideline